Operating from our distribution and administration centre in Dublin, FORTE Healthcare was established in 2003 in both the UK and Ireland primarily to market the unique Disease Modifying Osteo-Arthritis Drug, Cartrophen Vet.
In 2006 FORTE Healthcare (Europe) was established to market Cartrophen Vet in Poland where we are nowing enjoying growing success in this exciting and developing market. Continuing our growth, in 2009 we established a sales force in France where we are successfully bringing the exciting, unique message of Anarthron to French veterinary practices. (Anarthron is the name by which Cartrophen Vet is marketed in France).
In addition to Cartrophen Vet (anarthron), FORTE Healthcare is proud to represent the following leading manufacturers: